Chennai: Nearly a year after three people died and 20 others were hospitalised following allegations of drinking contaminated ...

Then David, who leads the Factor XI clinical program at Regeneron, will present preclinical data as well as clinical data from the ROXI-VTE-I and II studies in venous thromboembolism prevention post ...

Hutchmed unveiled new details on its expanding oncology pipeline and research strategy, including the launch of its ...

Research and development expense in fiscal Q3 2025 -- $4.5 million versus $4.9 million in fiscal Q3 2024. Net loss -- $5.9 ...

Rounding out Lakeville’s slate of major commercial construction projects is the Lakeville 35 Logistics Center, a ...

Revenue -- $1.2 million, representing a 32% increase, attributed primarily to higher procedure volumes for the Catamaran ...

The pipeline giant’s plan to expand the congested South West Pipeline reflects its wider grid expansion strategy to head off the need for LNG imports.

Q3 2025 Earnings Call Transcript November 3, 2025 BioNTech SE misses on earnings expectations. Reported EPS is $-0.14 EPS, ...

Harvard Business School invited the actress and entrepreneur to give a talk on entrepreneurship and female empowerment.

(4168, hereinafter referred to as GNX), today announced that the last patient has received the final dose in its Phase 3 clinical study of SPD8, a biosimilar to denosumab for the treatment of ...

Authorization Received from UK and EU Authorities to Activate ex-US Clinical Trial Sites Supporting the Ongoing Patient ...

Pfizer Inc. ( PFE) Discusses Clinical Development Strategy for 4404 Bispecific Antibody in Oncology November 10, 2025 8:30 AM EST ...